Skip to content

Clinical trials

Completed Observational Lung Diseases trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Lung Diseases Phase: Observational Status: Completed Clear all

283 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20007
200112
200210
20034
20046
20058
20069
20073
20094
20102
20115
20125
201310
20147
20154
20169
201713
20185
201911
202013
20219
202211
202311
20244
20252
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed283

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Heart, Lung, and Blood Institute (NHLBI)87
AstraZeneca7
University of Pittsburgh7
Weill Medical College of Cornell University6
Brigham and Women's Hospital5
National Institute of Environmental Health Sciences (NIEHS)5
Columbia University4
NYU Langone Health4
University of Wisconsin, Madison4
Milton S. Hershey Medical Center3

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Lung Diseases283
Asthma65
Pulmonary Disease, Chronic Obstructive40
Cardiovascular Diseases25
Heart Diseases25
Sleep Apnea Syndromes20
Cystic Fibrosis12
Lung Neoplasms12
Hypertension11
Neoplasms11

Trials

Showing 1 to 25 of 283. Each trial links to its page on Pharma Observatory.

183 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.